Belgium· BE-AMP-SAM597271-00
Droperidol Hikma 2.5 mg/ml
A droperidol product containing droperidol, registered in Belgium by Hikma Farmacêutica. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Droperidol is registered in 11 of 19 countries.
Countries holding a registration under ATC N05AD08 (droperidol), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Droperidol · ATC N05AD08
11 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Droperidol
- Manufacturer
- Hikma Farmacêutica
- Country
- Belgium (BE)
- ATC code
- N05AD08
- ATC class
- Droperidol
- Defined daily dose
- 2.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
273 interactions on record for droperidol.
Graded by severity as the source publishes them — 154 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Droperidol · interactions on record
273 records
- 154 severe
- 88 moderate
- 2 minor
- 27 info
Most severe, free to view
- PapaverineA03AD01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Droperidol in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainDROPERIDOL AGUETTANT 2,5 MG/ML SOLUCION INYECTABLE EFGLaboratoire Aguettant
- NorwayDridolSubstipharm
- SwedenDridol 2,5 mg/ml Injektionsvätska, lösningSubstipharm
- IcelandDridolSubstipharm
- FinlandDehydrobenzperidolProStrakan Ltd.
- FranceDROLEPTAN 1,25 mg/2,5 ml, solution injectableSUBSTIPHARM
- United KingdomDroperidol 1mg capsulesSpecial Order
- NetherlandsDehydrobenzperidol 0,5 mg/ml oplossing voor injectieSubstipharm
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Droperidol Aguettant, Droperidol Hikma
- Germany · Droperidol Aguettant, Droperidol Carinopharm
- Denmark · Dehydrobenzperidol Substipharm, Droperidol Aguettant
- Spain · Droperidol Hikma, Droperidol Kalceks
- Finland · Dehydrobenzperidol Substipharm, Droperidol Aguettant
- France · Droleptan, Droperidol Aguettant
- United Kingdom (Northern Ireland) · Droperidol Hikma Farmacêutica (Portugal), Droperidol Panpharma
- Greece · Xomolix
- Hungary · Droperidol Kalceks
- Ireland · Droperidol Aguettant, Droperidol Laboratoire Aguettant
- Iceland · Dridol, Droperidol Aguettant
- Italy · Droperidol Kalceks, Droperidolo Aguettant
- Luxembourg · Dehydrobenzperidol Substiparm, Dehydrobenzperidol Substipharm
- Latvia · Droperidol Kalceks
- Netherlands · Dehydrobenzperidol Iv Substipharm, Dehydrobenzperidol Substipharm
- Norway · Dridol, Droperidol Aguettant
- Portugal · Droperidol Aguettant, Droperidol Hikma
- Romania · Droperidol Aguettant
- Sweden · Dridol, Droperidol Aguettant
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb1ba4e1-ae0c-4218-8a2d-97f64866849c GET /v1/drugs/bb1ba4e1-ae0c-4218-8a2d-97f64866849c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Droperidol Hikma 2.5 mg/ml",
"name_fr": "Droperidol Hikma 2.5 mg/ml",
"name_nl": "Droperidol Hikma 2.5 mg/ml",
"amp_code": "SAM597271-00",
"strengths": [
"2.5000"
],
"pack_count": 2,
"substances": [
"Droperidol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Droperidol",
"authorisation_numbers": [
"BE597271"
]
}See everything about droperidol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.